Spatial chromatin accessibility sequencing resolves high-order spatial interactions of epigenomic markers

  1. BGI Genomics, BGI-Shenzhen, Shenzhen 518083, China
  2. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
  3. Department of Biology, Cell Biology and Physiology, University of Copenhagen 13, 2100 Copenhagen, Denmark
  4. Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150040, China

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a response from the authors (if available).

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Xiaobing Shi
    Van Andel Institute, Grand Rapids, United States of America
  • Senior Editor
    Detlef Weigel
    Max Planck Institute for Biology Tübingen, Tübingen, Germany

Joint Public Review:

In this manuscript, Xie et al report the development of SCA-seq, a multiOME mapping method that can obtain chromatin accessibility, methylation, and 3D genome information at the same time. This method is highly relevant to a few previously reported long read sequencing technologies. Specifically, NanoNome, SMAC-seq, and Fiber-seq have been reported to use m6A or GpC methyltransferase accessibility to map open chromatin, or open chromatin together with CpG methylation; Pore-C and MC-3C have been reported to use long read sequencing to map multiplex chromatin interactions, or together with CpG methylation. Therefore, as a combination of NanoNome/SMAC-seq/Fiber-seq and Pore-C/MC-3C, SCA-seq is one step forward. The authors tested SCA-seq in 293T cells and performed benchmark analyses testing the performance of SCA-seq in generating each data module (open chromatin and 3D genome). The QC metrics appear to be good and the methods, data and analyses broadly support the claims. However, there are some concerns regarding data analysis and conclusions, and some important information seems to be missing.

1. The chromatin accessibility tracks from SCA-seq seem to be noisy, with higher background than DNase-seq and ATAC-seq (Fig. 2f, Fig. 4a and Fig. S5). Also, SCA-seq is much less sensitive than both DNase-seq and ATAC-seq (Figs. 2a and 2b). This and other limitations of SCA-seq (high background, high sequencing cost, requirement of specific equipment, etc) need to be carefully discussed.

2. In Fig. 2f, many smaller peaks are present besides the major peaks. Are they caused by baseline DNA methylation? How many of the small methylation signals are called peaks? In Fig. 4a, it seems that the authors define many more enhancers from SCA-seq data than what will be defined from ATAC-seq or DHS. Are those additional enhancers false positives? Also, it is difficult to distinguish the gray "inaccessible segments" from the light purple "accessible segments.

3. For 3D genome analysis, it is important to provide information about data yield from SCA-seq. With 30X sequencing depth, how many contacts are obtained (with long-read sequencing, this should be the number of ligation junctions)? How is the number compared to Hi-C.

4. Fig 3j. Because SCA-seq only do GpC methylation, the capability to detect the footprint at individual CTCF peaks depends on the density of GpC nearby. Have the authors taken GpC density into account when defining CTCF sites with or without footprint?
5. This study only performs higher resolution chromatin interaction analysis based on individual read concatenates. It is unclear to me if the data have enough depth to perform loop analysis with Hi-C pipelines.

6. It appears that SCA-seq is of low efficiency in detecting chromatin interactions. As shown in Fig. S7a, 65.4% of sequenced reads contained only one restriction enzyme (RE) fragment/segment (with no genomic contact), which is much higher than that reported in published PORE-C methods. In addition, Fig. S7g is very confusing and in conflict with Fig. S7a. For example, in Fig. S7g, 21.4% and 22.2% of CSA-seq concatemers contain one and two segments, whereas the numbers are 65.4% and 14.7% in Fig. S7a, respectively. Please explain.

7. I disagree with the rationale of the entire Fig. S9. Biologically there is no evidence that chromatin accessibility will change due to genome interactions (the opposite is more likely), therefore the definition of "expected chromatin accessibility" is hard to believe. If the authors truly believe this is possible, they will need to test their hypothesis by deleting cohesin and check if the chromatin accessibility driven by "power center" are truly abolished. The math in Fig. S9 is also confusing. Firstly, the dimension of the contact matrix in Fig. S9 appears to be wrong, it should have 8 rows. Secondly, I don't understand why the interaction matrix is not symmetric. Third, if I understand correctly the diagonal of the matrix should be all 1, it is also hard to understand why the matrix only has 1, 0 or -1. It appears that the authors assume that the observed accessibility is a simple sum of the expected accessibility of all its interacting regions; this is wrong. In my opinion, the whole Fig. S9 should be deleted unless the authors can make sense of it and ideally also provide more evidence.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation